Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$136.52 – $192.13
86% from low
Exchange
ARCX
ETF
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| GVIPGoldman Sachs Hedge Industry VIP ETF | $184.22 | +1.74% | $582M | — |
| CAOSAlpha Architect Tail Risk ETF | $90.31 | -0.17% | $423M | — |
| CFOVictoryShares US 500 Enhanced Volatility Wtd ETF | $79.99 | +0.44% | $407M | — |
| DBJPXtrackers MSCI Japan Hedged Equity ETF | $114.05 | +0.25% | $487M | — |
| EFAXState Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF |
No company description on file.
No one on the platform currently holds GVIP.
No tracked institution reports a position in GVIP as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-23 | $0.5194 | 2025-12-30 |
| 2024-12-23 | $0.3546 | 2024-12-30 |
| 2023-12-26 | $0.7410 | 2024-01-02 |
No one on the platform has traded GVIP yet.
| $53.90 |
| +0.87% |
| $506M |
| — |
| EMQQEMQQ The Emerging Markets Internet ETF | $30.89 | +0.80% | $268M | — |
| GVUSGoldman Sachs MarketBeta Russell 1000 Value Equity ETF | $62.31 | +0.04% | $411M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
ABVX Stock Rockets 28% After Abivax Eases Drug Safety Concerns With Fresh Clinical Data $ABVX $IBB $GVIP https://stocktwits.com/news/equity/markets/abvx-stock-rockets-after-abivax-eases-drug-safety-concerns-with-fresh-clinical-data/cZ19pPuR7L8
View on StockTwits ↗ABVX Stock Clocks Worst Day Ever On Malignancy Signal For Drug: ‘Pharma Bro’ Says ‘GLPs Are Doing Fine’ After Similar Fears $ABVX $IBB $GVIP https://stocktwits.com/news/equity/markets/abvx-stock-clocks-worst-day-ever-on-malignancy-signal-for-drug-pharma-bro-weighs-in/cZ0SnP2ReDN
View on StockTwits ↗ABVX Tanks 30% After-Hours Despite 51% Remission In Ulcerative Colitis Trial — Rare Cancer Concerns Hit Sentiment $ABVX $IBB $GVIP https://stocktwits.com/news/equity/markets/abvx-tanks-after-hours-despite-51-percent-remission-in-ulcerative-colitis-trial/cZ0W40WRevK
View on StockTwits ↗$QQQ $GVIP Two And 20 In 2025 https://heisenbergreport.com/2025/08/25/two-and-20-in-2025/
View on StockTwits ↗$GVIP I like this etf… just not sure about it. Qqq has my attention now and vanguard as well etfs
View on StockTwits ↗$GVIP - Goldman Sachs max pain price is slumping to 90.0 https://www.macroaxis.com/stock-options/GVIP/Goldman-Sachs-Hedge?utm_source=dlvr.it&utm_medium=stocktwits
View on StockTwits ↗$GVIP: Considerably lower volume is observed in the last couple of days, which is a good thing during a pullback. https://www.chartmill.com/stock/quote/GVIP/technical-analysis?key=825cf61d-6811-44f6-b010-5d4f7b4fbc75&utm_source=stocktwits&utm_medium=TA&utm_content=GVIP&utm_campaign=social_tracking
View on StockTwits ↗$GVIP - Puts open interest is shifting for Goldman Sachs this week https://www.macroaxis.com/stock-options/GVIP/Goldman-Sachs-Hedge?utm_source=dlvr.it&utm_medium=stocktwits
View on StockTwits ↗$GVIP - Implied volatility is down to 8.157 for Goldman Sachs https://www.macroaxis.com/stock-options/GVIP/Goldman-Sachs-Hedge?utm_source=dlvr.it&utm_medium=stocktwits
View on StockTwits ↗$GVIP - Goldman Sachs max pain price is declining to 76.0 https://www.macroaxis.com/stock-options/GVIP/Goldman-Sachs-Hedge?utm_source=dlvr.it&utm_medium=stocktwits
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.